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Summary
Staphylococcus aureus (S. aureus) is one of the most important bacterial opportuni-
stic pathogens in humans. It easily adapts to the various environmental conditions. Very 
important is rapid development of resistance to different antimicrobial agents. Especially 
important is the resistance to beta-lactam antibiotics (so called methicillin-resistant S. 
aureus: MRSA). MRSA strains differ according to the setting they cause infections to 
healthcare-acquired strains, community-acquired strains and animal strains. Healthca-
re-acquired MRSA strains were responsible for the largest epidemic of healthcare-asso-
ciated infections that ever occurred in the world; community-acquired MRSA strains 
are huge problem in USA, not so important in Europe. Animal MRSA strains are new 
addition to human pathogens, but they are not very frequent. In Croatia, MRSA strains 
are big problem in hospitals but with the tendency of decreasing in recent years; co-
mmunity-acquired MRSA strains are so far very rare, and infections caused by animal 
MRSA strains are still not described in humans, although they are present in pig farms.
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S. aureus, in about 20-30% of people is a part of normal flora, most often in the 
area of the nasal vestibulum, but it may be found in the mucous membrane of the 
throat, the intestines, on the skin of the perineum, in the armpit and in the groins. 
S. aureus has many different virulence factors, which are responsible for the occu-
rrence of various clinical syndromes. So far more than 30 different virulence fac-
tors have been described, which lead to the occurrence of the disease in particular 
situations [1]. It causes a wide range of infections, from localized skin infections to 
life-threatening deep abscesses, osteomyelitis, pneumonia, sepsis, and endocarditis, 
various post-operative infections; S. aureus toxins can cause food poisoning, and 
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toxic shock syndrome [2,3]. S. aureus is a causative agent of about 10-12% of healthca-
re-associated infections. 
S. aureus adapts very easily to various environmental conditions (dessication, 
high concentrations of salt, low pH). Genomes of about ten strains of S. aureus have 
been completely sequenced and these genomes have been shown to contain a large 
number of mobile genetic elements, which means they very easily exchange genes 
horizontally with other microorganisms. This gives them the possibility of adapting 
to different situations in the environment, as well as in humans, enabling them to be 
harmless as colonization flora, but also to cause serious infections. 
Methicillin-resistant StaphylococcuS aureuS (Mrsa) 
an especially important characteristic of the adaptability of S. aureus is the fact 
that it can obtain very quickly resistance to various antibiotics. already about ten 
years after the discovery of penicillin, resistance appeared to penicillin, and today 
about 80-90% of strains of S. aureus produce beta-lactamase which destroys peni-
cillin [4,5]; directly after the introduction of methicillin into clinical practice (1959-
1960), the first methicillin resistant S. aureus (MRSA) was isolated. In 1961 in the 
United Kingdom, it was found in the blood of a patient with bacteraemia [6]. MRSA 
strains differ according to their sensitivity to other anti-staphylococcal antibiotics, 
but they are most often resistant to most of them. Reduced sensitivity and so-called 
hetero-resistance to vancomycin, today one of the primary drugs used for treating 
MRSA infection, was described in 1997 [7], and since 2002 several cases of resistan-
ce to vancomycin have been described - but it has not spread further than the few 
cases described [8,9]. However, an increase in minimal inhibitory concentrations 
of vancomycin is developing in MRSA strains, which is resulting in a reduction in 
the effectiveness of that drug too. The occurrence of MRSA strains has even been 
described to new drugs available in this country, that is, linezolid and daptomycin. 
mrsa strains have also developed resistance to all other antibiotics used to treat 
staphylococcal infection (macrolides, lincosamides, streptogramin B, quinolones, 
cotrimoxazol, rifampicin, fusidic acid). 
resistance to methicillin is mediated by the production of pBp 2a, coded by the 
gene meca, located within the staphylococcal chromosomal cassette SCCmec. pBp 
2a, in contrast to PBP in sensitive strains, has a very weak affinity for beta-lactam 
antibiotics, and mrsa strain is resistant to all beta-lactam antibiotics. To date, 11 
types of sccmec [10] have been recognized. SCCmec gene has a genetic structure 
like an island of pathogenesis, which is transferred horizontally from one strain of 
bacteria to another. Types 1, 2 and 3 have a large sccmec, within which there are 
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many genes of resistance to other antibiotics, but due to their size they are probably 
more difficult to transfer, and they have only been transferred to a few clones in the 
world, and therefore these MRSA strains are mainly clonal. These types of MRSA 
are widespread in health care institutions. Types 4-11 have smaller SCCmec, they are 
very mobile, contain less or no other resistance gene, and they spread very easily. 
MRSA strains with these types of SCCmec are mainly polyclonal and sensitive to 
most other antibiotics. They are widespread in the non-hospital (community) popu-
lation, but in some environments (USA) they are also widespread in hospitals. 
mrsa strains may be divided into three groups according to the environment 
where they are causing the infection: MRSA in health care institutions (hospital 
acquired MRSA), MRSA in the community (community acquired MRSA) and MRSA 
related to animals. 
Mrsa in health care institutions 
Since the appearance of the first strains in 1961, MRSA has been spread very 
quickly in hospitals all over the world. In 1963 it was isolated in Denmark, at the 
same time also in other European countries, and in Australia and the USA. The first 
MRSA epidemic was described in 1963 [11]. Data from the SENTRY program (1997-
1999) [12], showed that the spread of MRSA differs in various parts of the world: 46% 
in the Pacific area, 34% in the USA, 35% in Latin America, 26% in Europe, and only 
6% in Canada. Also, the variations were very great within each individual region, 
for example between Australia (27%) and Japan (70%) and in Europe between the 
Netherlands (<2%) and Portugal (54%). 
Today mrsa is one of the most common causes of healthcare-associated infec-
tion, causing 40-70% of staphylococcal infections in intensive care units [12]. Heal-
thcare-associated MRSA is a truly opportunistic pathogen, which causes infection 
in otherwise seriously ill patients, patients after major surgery, patients on haemo-
dialysis, patients with a indwelling catheters, stomas, and bed sores, but also inhabi-
tants of nursing homes. In these patients MRSA mainly causes post-surgical wound 
infections, pneumonia or sepsis. 
Taking the world as a whole, MRSA was responsible for the largest epidemic of 
healthcare-associated infections that ever occurred in the world [13,14,15]. Therefore 
it is an important not only public health, but also political problem in the entire 
world. In hospital conditions it spreads very easily from patient to patient, mainly 
by the hands of health workers [16], but it may spread through contaminated objects 
and also by air [17]. The scope of the spread of MRSA is shown in the example of the 
USA: in intensive care units MRSA was isolated in only 2% of staphylococcal infec-
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tions in 1974, in 1992 in 36% and in 2003 in as many as 64% [18]. A major problem is 
the fact that infections caused by MRSA have a significantly higher mortality rate 
than those caused by sensitive staphylococcus [19,20]. moreover, healthcare-associa-
ted infections caused by MRSA significantly increase the costs of hospital treatment 
[21]. 
Prevention of healthcare-associated infections by Mrsa 
strains
since the problem of infection by mrsa strains in hospital is very large, various 
preventive measures are taken, of which some have been shown to be very effective, 
whilst for others there is less evidence, but they are undertaken on the basis of the 
experience of some institutions or states. all these measures are included in guide-
lines which hospitals keep to, with more or less success. Many countries have na-
tional guidelines, including croatia [22,23,24]. With strict adherence to guidelines, 
many states in the world have recorded a reduction in the frequency of infection by 
mrsa strains. The most important preventive measures are included in a “bundle” 
of measures [25,26,27,28,29], which consist of the following procedures: hand hygie-
ne, decontamination of the environment and equipment, active selection of carriers 
on admission to hospital, contact isolation for colonized and infected patients (isola-
tion in single bed rooms), and the application of bundle care procedures for central 
vascular catheters. 
In the past twenty or so years, MRSA has also been spread to nursing homes 
and other long-term care facilities, where some residents are bed-ridden. This is not 
unusual, since serious staphylococcal infections are often found in older persons. 
The elderly, when they are admitted to hospital, are easily infected with strains of 
mrsa, and return to the nursing home as carriers. in nursing homes there is so-
metimes a very high percentage of MRSA carriers (7-46%) [30,31]. It has not been 
explained how far these MRSA carriers may infect other residents, but it has been 
shown that an MRSA carrier is an important risk factor for the occurrence of serious 
infection [32], infections in diabetics or patients with occlusive vascular disease [33] 
amongst those residents. 
coMMunity acQuired Mrsa
mrsa strains appeared about ten years ago in the community, causing infec-
tions in otherwise healthy people [34,35,36,37]. This did not happen however by 
the MRSA “leaving” the hospital, as was shown by further research: MRSA strains 
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in the community are different from those in hospitals in terms of bacteriological 
characteristics and the clinical syndromes they most often cause. As has already 
been mentioned, community acquired mrsa is not multi-resistant, the strains are 
mainly polyclonal (the exception is the clone USA 300, which is very widespread in 
the USA) [36,38]. The SCCmec types are from IV to VI and more recently up to XI (10). 
Community strains of MRSA very often produce Panton-Valentine toxin [36,37,39,40] 
which makes them highly pathogenic, especially if they also possess other pathoge-
nic factors, such as strain USA 300 [41,42]. Most often they cause infection of the skin 
and soft tissues, but also serious and often fatal necrotizing pneumonia [43,44], ne-
crotizing fasciitis and infections of the bones and joints [42,45]. In the USA, commu-
nity acquired MRSA spreads very quickly, and since these patients are very often 
hospitalized due to a serious form of the infection, strains of MRSA and especially 
USA 300 are also widespread in hospitals, especially paediatric wards [40]. In Euro-
pe community acquired MRSA is not a significant problem at the moment [46]. 
Mrsa related to aniMals
MRSA is also known as a pathogen in the field of veterinary medicine, found in 
various animals, from pets to livestock, horses, pigs, poultry, exotic animals, and as 
a cause of infection and colonizing flora in healthy animals [8]. In Europe this is an 
increasing problem, especially in connection with colonized pigs (MRSA strains of 
the sequenced type (ST) 398) from whom it is transferred and causes infections in 
pig farmers, veterinarians and workers in slaughter houses [46,48]. MRSA has also 
been found in meat from domestic animals [49], but the authors of that paper did 
not find the clone ST 398, but only types which may be found in both people and 
pigs. The MRSA clone ST 398 was discovered for the first time in the Netherlands in 
2003, and since then it has been found in other parts of the world, in other European 
countries, in Asia and the USA [50]. For now, however, this type of MRSA is respon-
sible for a very small proportion of mrsa infections in people [50]. in the republic 
of croatia mrsa strains have also been found in dust on pig farms [51].
Mrsa in the rePublic of croatia 
In Croatia the first report of the importance of MRSA strains was published in 
1997 [52]. At the end of the 1990’s work began in the Republic of Croatia to systema-
tically monitor the appearance of MRSA as part of the Committee for Monitoring 
resistance of Bacteria to antibiotics of the academy of medical science of croatia 
(HAMZ), and also as part of the European Union project EARSS (European Anti-
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microbial resistance surveillance system, today part of ecdc - monitoring isolates 
from the blood of patients with bacteraemia). In a study by EARSS for 2005-2006 in 
the Republic of Croatia, of 745 staphylococcal blood isolates from patients, it was 
shown that in male patients MRSA was found more often (46%) than in females 
(30%), that the highest frequency occurred at an older age (14% from 0-4 years, 20% 
from 5-19 years, 32% from 20-64 years and 45% at more than 65 years). It occurred 
most often on surgical wards (73%), in intensive care units (64%) and in medical war-
ds (22%). Eighteen of the largest hospitals in Croatia took part in the EARSS project, 
and MRSA appeared in a wide range of percentages: from 0% to 65%. MRSA strains 
isolated in Croatia were characterized on a molecular level and found their place in 
the epidemiological picture of mrsa isolates in europe [53,54,55]. 
In the Republic of Croatia, the frequency of MRSA in 2010 was 16% (Annual 
Report of the HAMZ Committee for Antimicrobial Resistance Surveillance), which 
is much lower than in previous years (25% in 2007). Also, data from the report on 
hospital infections (Annual Report of the Ministry of health and social welfare Co-
mmittee for Prevention and Control of Hospital Infections) show that the incidence 
of MRSA in clinical hospitals has decreased: the median in clinical hospitals fell 
from 0.66 patients per 1000 patient days in 2007 to 0.12 patients per 1000 patient days 
in 2010. 
Community acquired MRSA was described for the first time in this country in 
2005 [56], but so far the number of these strains is small and these strains were ma-
inly isolated from patients with minor skin and soft tissue infections [57]. 
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Sažetak
Značenje meticilin-rezistentnih sojeva Staphylococcus aureus (MRSA) u humanoj medicini
Staphylococcus aureus (S. aureus) jedan je od najznačajnijih bakterijskih oportunističkih pa-
togena u ljudi. Vrlo se lako adaptira na različite uvjete u okolini, a posebno je važno njegovo 
brzo stjecanje otpornosti na različite antibiotike. Osobito je važna otpornost na betalaktamske 
antibiotike (takozvani meticilin-rezistentni S. aureus: MRSA). Sojevi MRSA-e razlikuju se prema 
sredini u kojoj uzrokuju infekcije: bolnički stečeni, stečeni u izvanbolničkoj populaciji te oni po-
vezani s domaćim životinjama. Bolnički MRSA izazvao je najveću epidemiju bolničkih infekcija 
ikada opisanu u svijetu; izvanbolnički MRSA velik je problem u SAD-u, manji u Europi. Životinj-
ski sojevi MRSA-e novi su dodatak ljudskim patogenima, no ne s velikom učestalošću u svijetu. 
U Republici Hrvatskoj MRSA je velik problem u bolničkim ustanovama, s laganom tendencijom 
smanjenja posljednjih godina. Izvanbolnički MRSA zasad je vrlo rijedak, a infekcije životinjskim 
sojevima, premda su dokazane na svinjogojskim farmama, nisu još opisane.
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